Decreased FOXP3 levels in multiple sclerosis patients

被引:294
作者
Huan, J
Culbertson, N
Spencer, L
Bartholomew, R
Burrows, GG
Chou, YK
Bourdette, D
Ziegler, SF
Offner, H
Vandenbark, AA
机构
[1] Oregon Hlth & Sci Univ, Vet Affairs Med Ctr, Neuroimmunol Res, Portland, OR 97201 USA
[2] Oregon Hlth & Sci Univ, Vet Affairs Med Ctr, Tykeson MS Res Lab, Portland, OR 97201 USA
[3] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA
[4] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA
[5] Immune Response Corp, Carlsbad, CA USA
[6] Benaroya Res Inst, Seattle, WA USA
[7] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA
[8] Oregon Hlth & Sci Univ, Dept Anesthesiol & Perioperat Med, Portland, OR 97201 USA
关键词
FOXP3; Treg cells; multiple sclerosis;
D O I
10.1002/jnr.20522
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Autoimmune diseases such as multiple sclerosis (MS) may result from the failure of tolerance mechanisms to prevent expansion of pathogenic T cells. Our study is the first to establish that MS patients have abnormalities in FOXP3 message and protein expression levels in peripheral CD4(+)CD25(+) T cells (Tregs) that are quantitatively related to a reduction in functional suppression induced during suboptimal T-cell receptor (TCR) ligation. Of importance, this observation links a defect in functional peripheral immunoregulation to an established genetic marker that has been unequivocally shown to be involved in maintaining immune tolerance and preventing autoimmune diseases. Diminished FOXP3 levels thus indicate impaired immunoregulation by Tregs that may contribute to MS. Future studies will evaluate the effects of therapies known to influence Treg cell function and FOXP3 expression, including TCR peptide vaccination and supplemental estrogen. (c) 2005 Wiley-Liss, Inc.
引用
收藏
页码:45 / 52
页数:8
相关论文
共 32 条
[21]   Cutting edge:: Estrogen drives expansion of the CD4+ CD25+ regulatory T cell compartment [J].
Polanczyk, MJ ;
Carson, BD ;
Subramanian, S ;
Afentoulis, M ;
Vandenbark, AA ;
Ziegler, SF ;
Offner, H .
JOURNAL OF IMMUNOLOGY, 2004, 173 (04) :2227-2230
[22]   Multiple sclerosis:: a study of chemokine receptors and regulatory T cells in relation to MRI variables [J].
Putheti, P ;
Morris, M ;
Stawiarz, L ;
Teleshova, N ;
Kivisäkk, P ;
Pashenkov, M ;
Kouwenhoven, M ;
Wiberg, MK ;
Bronge, L ;
Huang, YM ;
Söderström, M ;
Hillert, J ;
Link, H .
EUROPEAN JOURNAL OF NEUROLOGY, 2003, 10 (05) :529-535
[23]   Circulating CD4+CD25+ T regulatory cells are not altered in multiple sclerosis and unaffected by disease-modulating drugs [J].
Putheti, P ;
Pettersson, A ;
Soderstrom, M ;
Link, H ;
Huang, YM .
JOURNAL OF CLINICAL IMMUNOLOGY, 2004, 24 (02) :155-161
[24]   Foxp3 and natural regulatory T cells: Key to a cell lineage? [J].
Ramsdell, F .
IMMUNITY, 2003, 19 (02) :165-168
[25]   Regulatory T cells: Key controllers of immunologic self-tolerance [J].
Sakaguchi, S .
CELL, 2000, 101 (05) :455-458
[26]  
SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151
[27]   Regulatory T cells in autoimmmunity [J].
Shevach, EM .
ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 :423-449
[28]  
TAI X, 2005, NAT IMMUNOL ONLINE, P1
[29]   Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis [J].
Viglietta, V ;
Baecher-Allan, C ;
Weiner, HL ;
Hafler, DA .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (07) :971-979
[30]   Antigen-dependent proliferation of CD4+ CD25+ regulatory T cells in vivo [J].
Walker, LSK ;
Chodos, A ;
Eggena, M ;
Dooms, H ;
Abbas, AK .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (02) :249-258